Risk factors for visual impairment registration due to diabetic retinopathy in Leeds, 2002-2005

Practical Diabetes International

Volumn 26, Issue 3, 2009, Pages 103-106

  Hayat, H ^a,b   Nayak, D ^c   Ashiq, A ^c   Goyder, E ^d   Bodansky, H J ^a   McKibbin, M ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b CHESTERFIELD ROYAL HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

HbA1c; Laser; Retinopathy; Visual impairment

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INCIDENCE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RISK FACTOR; RISK REDUCTION; SCREENING; TREATMENT FAILURE; UNITED KINGDOM; VISUAL IMPAIRMENT;

EID: 65949098883     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1348     Document Type: Article

References (15)

1. www.nscretinopathy.org.uk.
2. Yorkshire and Humber Public Health Observatory. www.yhpho.org.uk.
3. Arun CS, Ngugi N, Lovelock L, et al. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet Med 2003; 20(3): 186-190.
4. Bunce C, Wormald R. Leading causes Pract Diab Int April 2009 Vol. 26 No. 3 Copyrigh of certification for blindness and partial sight in England & Wales. BMC Public Health 2006; 6: 58.
5. McKibbin M, Walters G, O'Neill D. Current diabetic retinopathy screening by general practitioner practices in Leeds. Poster at the Royal College of Ophthalmologists Annual Congress, Cardiff, 1999.
6. www.dh.gov.uk/en/Publications andstatistics/Freedomofinformation publicationschemefeedback/FOI releases/DH_4112435.
7. Department of Health. The National Service Framework for Diabetes. London: Department of Health, 2002.
8. Bachmann MO, Nelson SJ. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health 1998; 52(1): 45-52.
9. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994; 101(6): 1061-1070.
10. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995; 102(4): 647-661.
11. Kohner EM, Stratton IM, Aldington SJ, et al; UK Prospective Diabetes Study (UKPDS) Group. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes in the UKPDS (UKPDS 52). Diabet Med 2001; 18(3): 178-184.
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837-853.
13. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998; 317: 703-713.
14. Rohan TE, Frost CD, Wald NJ. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ 1989; 299: 1198-1201.
15. Rhatigan MC, Leese GP, Ellis J, et al. Blindness in patients with diabetes who have been screened for eye disease. Eye 1999; 13(2): 166-169.